Roche Holding AG (OTCMKTS:RHHVF – Get Free Report)’s stock price dropped 1.8% during trading on Tuesday . The stock traded as low as $402.14 and last traded at $402.14. Approximately 321 shares were traded during trading, a decline of 97% from the average daily volume of 9,266 shares. The stock had previously closed at $409.6960.
Roche Stock Performance
The business has a 50 day simple moving average of $374.99 and a 200-day simple moving average of $345.33.
Roche Company Profile
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
See Also
- Five stocks we like better than Roche
- Wall Street Stockpicker Names #1 Stock of 2026
- Trump’s new AI budget just passed — one stock could soar
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
- Terrifying reason Trump killed the U.S. penny?
- Buy this $2 Gold Stock Before January 1, 2026
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
